Eisuke Adachi

National Institute of Infectious Diseases — Japan

Medicine · Health Sciences

41h-index5.6kcitations184works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(27), COVID-19 Clinical Research Studies(18), SARS-CoV-2 and COVID-19 Research(18), Gastric Cancer Management and Outcomes(17), Liver Disease Diagnosis and Treatment(16)

Publications184 total

Assessment of cellular and humoral immunity against varicella-zoster virus in adult allogeneic hematopoietic cell transplant recipients: a cross-sectional study assessing cellular immunity after administration of an adjuvanted recombinant zoster vaccine
Journal of Infection and Chemotherapy·2025
Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre‐Antiretroviral Therapy Era
Journal of Medical Virology·2025Open Access
Simultaneous detection of p24 antigen and antibody outside the acute phase of HIV infection: A case report
International Journal of STD & AIDS·2025
High rate of HCV reinfection and the efficacy of standard regimens in men who have sex with men living with HIV
Journal of Infection and Chemotherapy·2025
Month 12 outcomes of switching to long-acting cabotegravir + rilpivirine with an oral lead-in versus continuing bictegravir/emtricitabine/tenofovir alafenamide in the Phase 3b randomized SOLAR study
Journal of Infection and Chemotherapy·2025Open Access
Characterization of genetic mutations in hepatitis B virus isolated from HBsAg+/HBcAb+/HBsAb-/HBV DNA + Japanese blood donors
Scientific Reports·2025Open Access
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics
HIV Medicine·2025Open Access
Cognitive performance from infancy to adulthood in Japan from 1998–2001 to 2014–2019: A study using the Kyoto Scale of Psychological Development
Intelligence·2025Open Access
Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Journal of Infection and Chemotherapy·2025· 1 cited
MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders
Journal of NeuroVirology·2025· 4 citedOpen Access
Referee report. For: Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA) [version 1; peer review: 1 approved]
Faculty of 1000 Research Ltd·2025Open Access
Sexually Transmitted <i>Treponema pallidum</i> Subspecies <i>endemicum</i> Infection With Atypical Skin Manifestations Outside of Tropical Regions
Open Forum Infectious Diseases·2024Open Access
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study
AIDS and Behavior·2024· 12 citedOpen Access
Hepatitis B Virus Reactivation After Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody
Emerging infectious diseases·2024· 13 citedOpen Access
Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022
Archives of Virology·2024· 2 citedOpen Access
Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV
BMC Microbiology·2024· 13 citedOpen Access
Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine
AIDS Research and Therapy·2024· 9 citedOpen Access
Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus Rilpivirine
AIDS Research and Human Retroviruses·2024· 14 citedOpen Access
Characterization of mutations in Hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021-2022
Research Square (Research Square)·2023Open Access
Crisis management for the future: Building a platform to provide information on emerging and re-emerging infectious diseases from normal times in Japan
Global Health & Medicine·2023Open Access
page 1 of 10Next →

Frequent Co-authors

Michiko Koga(15), Makoto Saito(12), Hiroshi Yotsuyanagi(11), Yoshihiro Kawaoka(11), Seiya Yamayoshi(10), Kiyoko Iwatsuki‐Horimoto(10), Takashi Matsumata(9), Keizō Sugimachi(9), Atsuhiro Yasuhara(9), Masazumi Tsuneyoshi(8), Takeshi Okamura(8), Masaki Imai(7), Mutsumi Ito(7), Shinya Yamamoto(7), Takashi Maeda(7), Maki Kiso(6), Yuko Sakai‐Tagawa(6), Takeya Tsutsumi(6), Kazuhiko Ikeuchi(6), Eiji Tsujita(6)